These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 1103241)
21. Review of human renal transplantation at the Toronto General Hospital. Farrow GA; Wilson DR; Fenton SS; Hayman WP Can J Surg; 1973 Mar; 16(2):134-8. PubMed ID: 4570266 [No Abstract] [Full Text] [Related]
22. Supplemental report on thoracic duct drainage for immunosuppression. Fish J Transplant Proc; 1972 Dec; 4(4):467. PubMed ID: 4566788 [No Abstract] [Full Text] [Related]
23. Methyl prednisolone in the treatment of renal transplant rejection. Clarke AG; Salaman JR Clin Nephrol; 1974; 2(6):230-4. PubMed ID: 4141287 [No Abstract] [Full Text] [Related]
24. Evaluation of organ specificity in renal allograft enhancement with F(ab') 2 fragments. Shaipanich T; Wren S; von Haefen U; Koppenheffer T; Busch G; Wilson RE Transplant Proc; 1973 Mar; 5(1):581-3. PubMed ID: 4572116 [No Abstract] [Full Text] [Related]
25. Comparison of medroxyprogesterone and corticosteroids in the treatment of canine renal allografts. Macdonald AS; Falvey CF; Chan CC Can J Surg; 1972 Sep; 15(5):326-31. PubMed ID: 4560407 [No Abstract] [Full Text] [Related]
26. Use of OKT3 in kidney, pancreas, and liver transplantation. D'Alessandro AM; Pirsch JD; Melzer JS; Sollinger HW; Kalayoglu M; Reed A; Knechtle SJ; Belzer FO Transplant Proc; 1990 Aug; 22(4):1748-9. PubMed ID: 2117796 [No Abstract] [Full Text] [Related]
27. Simultaneous homotransplantation of heart and kidney from the same donor in bilaterally nephrectomized dogs. Legrain M; Gandjbakhch ; Dubois M; Wajcner G; Rottembourg J; Guilmet D Transplant Proc; 1969 Mar; 1(1):293-5. PubMed ID: 4944230 [No Abstract] [Full Text] [Related]
28. Monitoring of renal allografts under immunosuppression. Hammer C Z Exp Chir Transplant Kunstliche Organe; 1986; 19(6):340-2. PubMed ID: 3548110 [No Abstract] [Full Text] [Related]
29. Immunosuppressive drugs used in clinical renal transplantation. Chatterjee SN Urology; 1977 Jun; 9(6 Suppl):52-60. PubMed ID: 70101 [No Abstract] [Full Text] [Related]
30. Hyperacute rejection of renal allografts in the primate: protective effect of F(ab') 2 fragment of hyperimmune serum. Kobayashi K; Hricko GM; Habal MB; Lukl P; Busch GJ; Hunsicker L; Reisner GS; Birtch AG Transplantation; 1972 Sep; 14(3):374-81. PubMed ID: 4629283 [No Abstract] [Full Text] [Related]
31. Aggressive needle biopsy protocol prevents loss of renal allografts to undetected rejection during early posttransplant dysfunction. Thistlethwaite JR; Woodle ES; Mayes JT; Stuart JK; Heffron TG; Spargo BH; Stuart FP Transplant Proc; 1989 Feb; 21(1 Pt 2):1890-2. PubMed ID: 2652614 [No Abstract] [Full Text] [Related]
32. The influence of immunosuppression on the prevalence of aseptic bone necrosis after renal transplantation. Cotorruelo JG; De Francisco AL; Canga E; Amado JA; Riancho JA; De Bonis E; Zubimendi JA; Ruiz JC; Sanz de Castro S; Arias M Transplant Proc; 1991 Aug; 23(4):2199-200. PubMed ID: 1871842 [No Abstract] [Full Text] [Related]
33. Posttransplant renal allograft dysfunction as a prognostic factor in triple therapy-treated patients. Pallardó LM; García J; Sánchez J; Górriz JL; Orero E; Calabuig F Transplant Proc; 1992 Feb; 24(1):113-4. PubMed ID: 1539199 [No Abstract] [Full Text] [Related]